
Rockwell Medical (RMTI) Stock Forecast & Price Target
Rockwell Medical (RMTI) Analyst Ratings
Bulls say
Rockwell Medical is viewed positively because it has regained compliance with Nasdaq listing requirements after the 1-for-10 reverse split, removing an overhang while preserving its listing on the Nasdaq Capital Market. Fundamentally, 2Q26 showed commercial traction with revenue of $17.8M, up 11% from $16.1M in 2025, driven by new Western U.S. customers and higher ordering from existing accounts, while cash, cash equivalents and marketable securities rose to $24.8M and free cash flow from operations was $2.1M. Although higher operating expenses widened the quarterly loss to $0.34 per share, the company’s scale, improving margins and efficiency, and a DCF framework implying about $89M in total firm value support the positive outlook.
Bears say
Rockwell Medical is viewed negatively because the company is expected to underperform a passive index of peers in the same sector, signaling weak relative fundamentals and limited investor appeal. As a healthcare supplier focused on hemodialysis concentrates and mixers, its business depends heavily on dialysis-provider demand, efficient logistics, and sustained commercial execution across the United States and international markets, leaving it vulnerable to operational and competitive pressures. The breadth of products such as CitraPure, RenalPure, and SteriLyte does not appear sufficient to offset the market’s expectation of subpar performance, reinforcing a cautious outlook on the stock.
This aggregate rating is based on analysts' research of Rockwell Medical and is not a guaranteed prediction by Public.com or investment advice.
Rockwell Medical (RMTI) Analyst Forecast & Price Prediction
Start investing in Rockwell Medical (RMTI)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Rockwell Medical (RMTI) Forecast
Rockwell Medical (RMTI) Analyst Forecast & Price Prediction
Start investing in Rockwell Medical (RMTI)
Order type
Buy in
Order amount
Est. shares
0 shares